TempTraq® Continuous Real-Time Body Temperature Monitoring System
What is TempTraq?
TempTraq is an FDA Cleared Class II medical device that gives Healthcare providers the first wireless continuous temperature monitor in the form of a soft, comfortable, disposable patch. TempTraq can significantly improve the way temperature is measured in the clinical environment and provide clinicians a quicker, easier, and more effective way to measure temperature.
Accuracy and equivalency in three hospital studies
- Cleveland Clinic
- University Hospitals Seidman Cancer Center
- Cincinnati Children’s Hospital
Earlier fever detection
In a clinical study conducted by University Hospitals Seidman Cancer Center, TempTraq was shown to detect temperature rise earlier than the Standard of Care by a median of 140.1 minutes (range of 30-180 minutes) with bone marrow transplant patients.2
Brochure: TempTraq by Vermed brochure
Earlier Fever Detection
Early detection of fever and prompt use of broad-spectrum
antibiotics is crucial in neutropenic patients:
- 78% of patients who received an allogeneic HSCT had
bacteraemia during the first episode of fever.4
- An hour delay in antibiotic administration resulted in an
approximately eight hour increase in length of hospital stay
among patients with febrile neutropenia.5
Remote Patient Monitoring
Hospitals seeking to improve patient care, reduce readmissions, optimize reimbursements and gain competitive advantage, are rapidly embracing new technologies that enable remote patient monitoring.
TempTraq provides a proven, reliable system to remotely
monitor patients for fever spikes, a key symptom of infection.
It also allows for self-monitoring through a smartphone app.
Septicemia is the costliest condition treated by U.S. hospitals,
accounting for $20.3 billion, or 5.2%, of all hospital costs.6
Severe sepsis accounts for an estimated 40% of all ICU
expenditures.7 In addition, sepsis cases present:
- Average length of stay of 19.6 days8
- Average cost per case of $22,1008
- Overall hospital mortality rate of 28%8
- ICU treatment cost of 6X more than non-sepsis patients9
It is crucial to recognize neutropenic fever early and to commence broad spectrum empiric antibiotics promptly in order to avoid sepsis syndrome and possible death.
The TempTraq system fits seamlessly into existing nurse workflow, increasing productivity by automatically capturing and entering temperature data into the EHR.
TempTraq patch monitors a patient’s temperature in real time and wirelessly uploads data to our HIPAA-compliant cloud server. Data from the secure server can be integrated via HL-7 standards with Electronic Health Records, central nurse workstations, patient bedside monitors and mobile devices to provide clinicians with temperature data visualization and mapping of data to the desired patient record fields.
The system is scalable and can support a single hospital or a multi-hospital/physician group healthcare system.
FDA ClearedClass II medical device
Operating Life72 hours; disposable/single use
Accuracy RatingConforms with ASTM E1112-00 (2011) +/- 0.1°C or +/- 0.2°F
WirelessBluetooth low energy
PowerEco-friendly, 2 – 1.5-volt carbon zinc batteries
SafeFor all ages and all skin types
Temperature displayFahrenheit or Celsius
AlertsAudible and/or visual notifications of rising temperature via applications
Once activated, TempTraq continuously monitors axillary temperature for up to 72 hours per patch, and issues alerts when temperature rises.
Clinically tested to be in alignment with core body temperatures.
Data transmits via Bluetooth, allowing patient freedom of movement.
TempTraq applies easily to patient with a gentle adhesive.
Patients can be remotely monitored with via TempTraq Connect’s secure, HIPAA compliant cloud service.
The TempTraq system can be integrated with existing EHR’s and monitoring systems, a deeper data set than the existing Standard of Care.
1. “Accuracy and Precision Test of TempTraq® Compared to Pulmonary Artery Catheter for Monitoring Temperature in Adults in Intensive Care Unit” / Sandra L. Siedlecki, PhD, RN, CNS / Cleveland Clinic
2. “Feasibility of Continuous Monitoring of Body Temperature for Patients Undergoing Stem Cell Transplant or High-Dose Chemotherapy” / Ehsan Malek, MD and Nina Dambrosio, MSN, CNP / University Hospital – Seidman Cancer Center / February 2017 /
3. “Continuous Temperature Monitoring in the Inpatient Setting Using TempTraq® / Megan Sampson, MD; Victoria Hickey, RN; John Huber, MSc; Priscila Davila, MD1; Jon Eager, BSEE; Stella Davies, MBBS, PhD; Christopher Dandoy, MD, MS / Cincinnati Children’s Hospital Medical Center, Blue Spark Technologies /
4. Support Care Cancer. 2010 Jan; 18(1): 37–42. / Continuous non-invasive monitoring of the skin temperature of HSCT recipients / Maarten van Vliet, corresponding author J. Peter Donnelly, Carin M. J. Potting, and Nicole M. A. Blijlevens
5. Time to antibiotics and outcomes in cancer patients with febrile neutropenia / Thomas Perron, Mohamed Emara and Shahid Ahmed Email author / BMC Health Services Research 2014 14:162 / DOI: 10.1186/1472-6963-14-162
6. Torio CM, Andrews RM. National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. HCUP Statistical Brief #160. August 2013.
7. Bone, CHEST 1992; 101:1644-55
8. Angus Crit. Care Med. 2001; 29:1303-1310
9. Edbrooke, Crit. Care Med. 1999; 27: 1760 – 1767 /7. Kumar A, Crit. Care Med. 2006 Jun; 34(6):1589-96.